Grow Therapy's $150M Series D targets the US mental health gap
What's the deal? Grow Therapy has raised $150 million in a Series D round to expand its mental health platform across insurers, employers, and health systems. The round was led by TCV and Growth Equity at Goldman Sachs Alternatives.
Why now? The US mental health system remains badly fragmented — long waitlists, opaque insurance rules, and a broken handoff between employee assistance programmes and ongoing care. Grow is launching a redesigned employer benefit in March 2026 that lets employees transition from EAP coverage to insurance without switching therapists, directly tackling one of the most common drop-off points in mental healthcare.
The numbers back up the momentum. In 2025, Grow facilitated seven million visits, bringing its lifetime total to 10 million appointments. It has grown from 75 to more than 125 insurer partnerships — including Medicare and Medicaid in most states — giving it reach to 220 million people. On average, clients pay $21 per visit; one in three pays nothing.
What could go wrong? Mental health is a heavily regulated, payer-dependent space where margins are tight and scale is hard. Grow's model relies on deep insurer partnerships, which take time and are difficult to maintain at volume.
Its AI notetaking and between-session tools are promising, but clinical tools in therapy carry meaningful liability and accuracy risks. The company claims 80% of clients see measurable improvement within 30 days — a bold assertion that will face scrutiny as it grows.
The signal: Grow's raise is the latest sign that mental health infrastructure — not just apps, but the unglamorous plumbing of insurance, scheduling, and care coordination — is attracting serious capital. The $150 million round follows an $88 million Series C in 2024, reflecting sustained investor conviction.
As employers and health systems look for ways to reduce costs tied to untreated mental illness, platforms that can bridge payers and providers at scale are increasingly attractive. Grow is betting that fixing the system's handoffs, not just adding more therapists, is where the durable value lies.
Sources:
Bloomberg
TFN
Grow Therapy
Image credits: Grow Therapy
A.M.
